Adding Todos Medical (TODMF) $0.03 to SuperBug Stock Review Watchlist.
Wall Street's War Against SuperBugs.
LIVE QUOTE
SuperBug Stock Review?...
VirnetX (VHC) Scores $440 Million and Citius Pharma (CTXR) Sees Market Expand to Over...
Internet Stock Review
Blast from the past scores big!
We added VirnetX (VHC)...
Fortress Bio (FBIO) Inches Closer to $3.00 on Major News.
Fortress Bio (FBIO) Inches Closer to $3.00 on Major News.
Citius Pharma (CTXR) Inches Closer to the Next Phase...
Okay, so What’s Next for Citius Pharma (CTXR) $1.16?
Dawson James Broker/Dealer Updates. Price Target Remains at $7.00.
"OK, So what’s Next? Topline data from the superior efficacy...
Citius Pharma (CTXR) $1.20. Price Target Upped to $4.00 at HC Wainright.
STREET INSIDER
H.C. Wainwright analyst Vernon Bernardino raised the price target on Citius Pharmaceuticals...
VIDEO: Dyadic (DYAI) CEO Explains What his Industry is Doing to Defeat Coronavirus (FoxNews).
Jan. 27, 2020 - 5:24 - Dyadic International CEO Mark Emalfarb discusses what’s being done to stop...
CoronaVirus Watch List Stocks in the News (Bloomberg, Benzinga).
INITIAL WATCHLIST: CoronaVirus Watch List | Superbug Stock Review
Aethlon Medical, Inc. (NASDAQ: AEMD) $2.40 Alpha Pro Tech, Ltd. (NYSE: APT)...
New Report: Citius Pharma (CTXR) Now Our #1 Ranked Idea for 2020.
Citius Pharmaceuticals (CTXR) is hands down one of the most exciting long-term opportunities we have come across since we first launched the...
Citius Pharma (CTXR) Corporate Presentation (Jan 2020).
In the above graphic, the catheter can get infected by bacteria and most typically see evidence of the infection (see gross graphic...
Armistice Capital Master Fund Ltd., and Citius Pharma (CTXR).
April 2019 Offering
On April 1, 2019, Citius entered into securities purchase agreements with institutional investors and accredited investors...